The instance recommends “to expand the Pfizer vaccine administration to the children” at risk of serious form “, but returns the generalization in France to later.
by
Do not rush. Do not turn pediatrician associations. Ensure especially that all precautions have been taken. Five days after the green light given by the European Agency for Immunization of 5-11 years with the vaccine Pfizer, the High Authority of Health (HAS) has chosen caution. In A opinion rendered Tuesday, November 30 , it recommends to the government to “expand” the campaign to children at risk of serious form. On the other hand, it conditions the generalization of vaccination at a series of “stakeholder auditions” and the expected studies in the coming weeks. So, and then only, it will be possible to “assess the relevance” of this new phase.
As since the beginning of the pandemic, the has therefore continues its strategy by stages, starting, once again, by “at risk” subjects. Of the 5,77 million children of 5-11 years old living in France, 1,284 were hospitalized after a CIVID-19, 226 had to be placed in critical care and three died. Very low figures, compared to the tribute paid by adults, but especially unevenly distributed. Based on the specialized literature, the has identified a particularly sensitive group of pathologies. They affect a total of 364,000 children, or 6.3% of all, but cumulate 21% of the severe forms of the disease.
The notice draws up a detailed list: congenital heart disease, chronic hepatic disease, cardiac disease or chronic respiratory disease (including severe asthma), neurological disease, pathological immunodeficiency or drug-induced, obesity, diabetes, malignant hemopathy, sickle disease Trisomy 21. For these children, the “direct individual profit” of vaccination appears established. Has does not stop there. It considers it prudent to vaccinate the children “bearers of one of the comorbidities identified in adults and at risk of developing a serious form of the disease”: recent cancer, chronic renal disease or neurological handicap.
One third of the adult dose
“Finally, we wanted to leave specialized practitioners the opportunity to recommend, on a case-by-case basis, the vaccination of children who seem particularly vulnerable to them,” says Lise Alter, Director of Evaluation and Access to Innovation at HAS. Last retained category: children living in the entourage of immunocompromised people. Some of these children had sometimes been immunized in particular protocols. All will now receive the dosage recommended by Pfizer: two injections of 10 micrograms, three weeks apart, or one third of the adult dose.
You have 39.72% of this article to read. The rest is reserved for subscribers.